by Team Small News | Aug 25, 2025 | Cipla, Glenmark, Lupin, Mankind, Pharma
Several Indian pharmaceutical companies, including Cipla, Glenmark, Lupin, and Mankind Pharma, have demerged their consumer healthcare businesses to focus on growth and expansion. This trend is also being seen globally, with companies like GlaxoSmithKline, Johnson and... by Team Small News | Aug 20, 2025 | Glenmark, Pfizer, Pharma
Glenmark Pharmaceuticals Inc. USA and Pfizer Inc., along with its generic-drug unit Greenstone LLC, have reached a settlement agreement to resolve price-fixing claims brought by direct purchasers of generic drugs. According to the terms of the agreement, Glenmark... by Team Small News | Jul 4, 2025 | Cipla, Glenmark, Lupin, Mankind, Pharma
Lupin, a leading pharmaceutical company, has created a new subsidiary called LupinLife Consumer Healthcare Ltd to house its consumer healthcare business. This move is in line with a growing trend among pharmaceutical companies, both in India and globally, to separate... by Team Small News | Jun 27, 2025 | Glenmark, Pharma
Alexey Cherchago, a leading expert in the pharmaceutical industry, recently discussed Glenmark’s focus on innovation and technology in the evolving pharmaceutical market. Glenmark, a global pharmaceutical company, has been at the forefront of innovation,... by Team Small News | Jun 19, 2025 | Glenmark, Pharma
The U.S. Food and Drug Administration (FDA) recently conducted a Good Manufacturing Practice (GMP) inspection of Glenmark Pharmaceuticals’ manufacturing facility in Monroe, North Carolina. The inspection, which took place from June 9-17, resulted in the FDA... by Team Small News | Jun 18, 2025 | Glenmark, Pharma
Glenn Saldanha, Chairman and Managing Director of Glenmark Pharmaceuticals Ltd, reflects on the company’s over two-decade journey, highlighting the challenges of transitioning from a generic-focused business to a more innovative space. Saldanha notes that this...